ZINOLI, LINDA
 Distribuzione geografica
Continente #
EU - Europa 1.632
Totale 1.632
Nazione #
IT - Italia 1.632
Totale 1.632
Città #
Genova 1.101
Rapallo 292
Genoa 234
Bordighera 5
Totale 1.632
Nome #
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome 146
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study 113
Prognostic value of preoperative serum levels of periostin (PN) in early breast cancer (BCa) 109
Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death 100
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes 100
Prognostic value of nuclear matrix protein expression in localized prostate cancer. 100
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients 95
Periostin: A Novel Prognostic and Therapeutic Target For Genitourinary Cancer? 92
Immunohistochemical detection of FMRFamide-related peptides in a primitive nervous system 83
68P * Prognostic value of periostin (PN) expression in early breast cancer (BCa): Long-term mortality outcomes 83
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer 78
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study 77
Cardiovascular disease (CVD) markers in patients(pts) with prostate cancer(PCa) treated with GN-RH agonists(AG) or antagonist(AN): a prospective cohort study 70
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes 68
Insights from a long-term follow-up evaluation of early breast cancer (BC) outcomes by tumor subtype (TS) 66
THE PROGNOSTIC VALUE OF PERIOSTIN EXPRESSION IN HUMAN PROSTATE CANCER 59
Insights from a Long-Term Follow-Up Evaluation of Early Breast Cancer Outcomes by Tumor Subtype 53
Prognostic value of Periostin expression in human prostate cancer 47
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer 44
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer 43
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review 29
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives 23
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy 16
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 11
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer 3
Totale 1.708
Categoria #
all - tutte 5.933
article - articoli 5.748
book - libri 0
conference - conferenze 185
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 0 20 20
2019/2020516 13 11 14 23 85 73 69 37 39 80 53 19
2020/2021200 7 18 11 47 7 10 2 27 13 31 8 19
2021/2022277 4 13 14 27 19 25 5 63 18 30 24 35
2022/2023332 19 40 7 25 71 48 0 32 47 1 39 3
2023/2024205 6 23 10 26 25 50 19 10 8 28 0 0
Totale 1.708